Recombinant Bdellovibrio bacteriovorus 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline for your reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
menD; Bd34842-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase; SEPHCHC synthase; EC 2.2.1.9; Menaquinone biosynthesis protein MenD
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Bdellovibrio bacteriovorus (strain ATCC 15356 / DSM 50701 / NCIB 9529 / HD100)
Target Names
menD
Uniprot No.

Target Background

Function
This enzyme catalyzes the thiamine diphosphate-dependent decarboxylation of 2-oxoglutarate, followed by the addition of the resulting succinic semialdehyde-thiamine pyrophosphate anion to isochorismate. This reaction yields 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate (SEPHCHC).
Database Links

KEGG: bba:Bd3484

STRING: 264462.Bd3484

Protein Families
TPP enzyme family, MenD subfamily

Q&A

What is Bdellovibrio bacteriovorus and why is its menD enzyme of interest to researchers?

Bdellovibrio bacteriovorus is a predatory delta-proteobacterium that invades other gram-negative bacteria, replicating within the periplasmic space of its prey. Unlike conventional bacteria, B. bacteriovorus exhibits a unique septation pattern during replication, producing both odd and even numbers of progeny to optimize use of finite prey resources . The menD enzyme (2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase) from B. bacteriovorus is of particular interest because it catalyzes a critical step in menaquinone (vitamin K) biosynthesis. This thiamine diphosphate (ThDP) and metal-ion-dependent enzyme performs a Stetter-like conjugate addition reaction that represents the first committed step in the menaquinone pathway . Researchers study this enzyme not only for its fundamental role in bacterial metabolism but also for its potential biotechnological applications in biocatalysis and therapeutic development.

How does the structure of B. bacteriovorus menD compare to orthologous enzymes from other bacterial species?

The structure of B. bacteriovorus menD shares the core catalytic domain architecture with other bacterial menD enzymes, featuring ThDP-binding motifs and metal coordination sites. While direct structural data for B. bacteriovorus menD is limited in the provided sources, comparative analysis with the characterized E. coli menD structure reveals that these enzymes typically exhibit low sequence identity (20-30%) across different organisms . The E. coli menD structure has been resolved as a complex with ThDP and Mn²⁺, providing a template for understanding the active site organization in B. bacteriovorus menD. Key structural elements include the ThDP-binding pocket, metal coordination sphere, and substrate recognition domains that facilitate the interactions with α-ketoglutarate and isochorismate . These structural insights are crucial for understanding the enzyme's catalytic mechanism and for engineering variants with modified activities.

What is the physiological role of menD in B. bacteriovorus lifecycle and predation?

The menD enzyme catalyzes a crucial step in menaquinone biosynthesis, which is essential for the electron transport chain in B. bacteriovorus. Menaquinone functions as an electron carrier in the respiratory chain, enabling energy generation during both the attack phase and the intraperiplasmic growth phase of the predatory lifecycle. This energy production is particularly critical during the highly energy-demanding processes of prey invasion, intraperiplasmic replication, and synchronized septation that characterizes B. bacteriovorus development . The predatory lifecycle involves attachment to prey bacteria, penetration of the prey cell wall, establishment within the periplasmic space, and replication using prey cell resources. Throughout this process, functional electron transport chains supported by menaquinone are essential for maintaining the energetic requirements of predation and replication within the constrained environment of the prey cell.

What are the optimal protocols for cloning and expressing recombinant B. bacteriovorus menD?

Based on established procedures for B. bacteriovorus genetic manipulation, the following methodological approach is recommended for cloning and expressing recombinant menD:

  • Gene Amplification: PCR-amplify the menD gene from B. bacteriovorus HD100 genomic DNA using high-fidelity polymerase and primers designed with appropriate restriction sites.

  • Vector Construction: Clone the amplified gene into an expression vector (such as pET series for E. coli expression) using restriction enzyme digestion and ligation.

  • Transformation and Expression: Transform the construct into an appropriate E. coli expression strain (BL21(DE3) or derivatives). Culture in LB medium at 30°C until OD₆₀₀ reaches 0.6-0.8, then induce with IPTG (0.1-0.5 mM) and continue cultivation at 18-20°C for 16-20 hours to minimize inclusion body formation .

  • Protein Purification: Harvest cells by centrifugation, lyse using sonication or pressure-based methods in buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, and 5 mM β-mercaptoethanol. Purify using immobilized metal affinity chromatography followed by size-exclusion chromatography.

  • Activity Verification: Assess enzyme activity using coupled spectrophotometric assays that monitor the consumption of α-ketoglutarate or the formation of the carboligation product .

For researchers requiring chromosomal integration or mutation of menD in B. bacteriovorus itself, a conjugation-based approach utilizing the suicide vector pK18mobsacB can be employed, as demonstrated for other genes in this organism .

How can researchers establish effective enzyme activity assays for B. bacteriovorus menD?

Several complementary approaches can be employed to quantitatively assess menD activity:

Spectrophotometric Assays:

  • ThDP-Dependent Decarboxylation: Monitor the decarboxylation of α-ketoglutarate by following the decrease in absorbance at 340 nm when coupled with NADH oxidation through suitable auxiliary enzymes.

  • Product Formation: Measure the formation of 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate using HPLC with UV detection at 278 nm.

Carboligation Activity Analysis:
For assessing the non-physiological 1,2-addition carboligation activity:

  • Prepare reaction mixtures containing 0.5 mg/ml purified enzyme, 50 mM potassium phosphate (pH 7.0), 2.5 mM MgCl₂, 0.1 mM ThDP, 20 mM α-ketoglutarate, and 10 mM benzaldehyde derivative.

  • Incubate at 30°C for defined time periods (30 min to 24 h).

  • Analyze products by HPLC using a chiral column for determination of enantioselectivity .

Table 1: Recommended Parameters for menD Activity Assays

ParameterPhysiological ReactionCarboligation Reaction
Buffer50 mM HEPES, pH 7.550 mM K-phosphate, pH 7.0
ThDP0.1 mM0.1 mM
Metal ion2.5 mM MgCl₂2.5 mM MgCl₂
α-ketoglutarate5 mM20 mM
Isochorismate1 mM-
Aldehyde acceptor-10 mM
Temperature30°C25-30°C
Analysis methodHPLCChiral HPLC

These assay conditions can be optimized based on specific research objectives and available instrumentation .

What strategies can be employed for engineering B. bacteriovorus menD variants with altered substrate specificity?

Engineering B. bacteriovorus menD variants with modified substrate specificity can be accomplished through several complementary approaches:

  • Structure-Guided Mutagenesis: Using homology models based on E. coli menD structure, identify residues in the active site that interact with substrates. Focus on residues within 5Å of the bound substrates for site-directed mutagenesis to alter specificity .

  • S-Pocket Engineering: Apply the "S-pocket concept" demonstrated successful for B. subtilis menD, which involves modifying residues that form a pocket accommodating the S-enantiomer. Key residues equivalent to I476 and F477 in the B. subtilis enzyme can be mutated to alter enantioselectivity. Importantly, consider second-shell residues adjacent to these positions, as glycine residues in this region provide structural flexibility that influences selectivity .

  • Domain Swapping: Exchange substrate-binding domains between B. bacteriovorus menD and orthologous enzymes with different specificities.

  • Directed Evolution: Establish a high-throughput screening system for menD variants generated by error-prone PCR or DNA shuffling, selecting for desired substrate utilization patterns.

A methodical approach combining rational design with evolutionary strategies has proven particularly effective. For example, engineering menD variants from B. subtilis achieved shifts from R-selectivity to S-selectivity with enantiomeric excess (ee) values of up to 98% for meta-substituted benzaldehyde derivatives .

How does the catalytic mechanism of B. bacteriovorus menD differ from other ThDP-dependent enzymes?

The ThDP-dependent catalytic mechanism of B. bacteriovorus menD involves several distinct steps that differentiate it from other ThDP-dependent enzymes:

  • Activation of ThDP: The thiazolium ring of enzyme-bound ThDP is deprotonated at C2, forming a reactive ylide. This step is common to all ThDP-dependent enzymes but may involve different active site residues in B. bacteriovorus menD.

  • Nucleophilic Attack on α-ketoglutarate: The ThDP ylide attacks the carbonyl carbon of α-ketoglutarate, forming a covalent ThDP-substrate adduct known as a lactyl-ThDP intermediate.

  • Decarboxylation: The intermediate undergoes decarboxylation, generating a resonance-stabilized carbanion/enamine species (succinyl-ThDP).

  • Stetter-like Conjugate Addition: Unlike many ThDP-dependent enzymes that perform simple decarboxylation or benzoin-type condensations, menD catalyzes a Stetter-like 1,4-addition of the succinyl-ThDP carbanion to isochorismate. This step represents a relatively rare reaction type among ThDP-dependent enzymes .

  • Product Release: The resulting 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate is released, regenerating the enzyme.

Metal ions (typically Mg²⁺ or Mn²⁺) play crucial roles in stabilizing the diphosphate moiety of ThDP and potentially in orienting substrates. While the general mechanism follows that of other ThDP-dependent enzymes, the particular substrate combination and the Stetter-like addition represent distinctive features of menD enzymes .

What implications does the unique cell division pattern of B. bacteriovorus have for recombinant protein expression systems?

The distinctive cell division pattern of B. bacteriovorus presents both challenges and opportunities for recombinant protein expression:

For practical recombinant expression purposes, conventional hosts like E. coli remain preferable for B. bacteriovorus proteins, though understanding the native regulatory mechanisms may inform the design of expression constructs and conditions .

How can researchers exploit the carboligation potential of B. bacteriovorus menD for biocatalytic applications?

The carboligation activity of B. bacteriovorus menD offers significant potential for biocatalytic applications, particularly in asymmetric synthesis of α-hydroxy ketones. Based on findings with related menD enzymes, researchers can exploit this potential through the following approaches:

  • Substrate Scope Exploration: Systematically investigate the acceptance of various aldehyde acceptors, focusing on benzaldehyde derivatives with different substitution patterns. Based on studies with B. subtilis menD, meta-substituted benzaldehydes are likely to be particularly good substrates .

  • Reaction Engineering:

    • Optimize reaction conditions (pH, temperature, co-solvent systems) to enhance activity and stability

    • Develop continuous-flow systems for improved productivity

    • Explore biphasic reaction systems to overcome substrate solubility limitations and facilitate product extraction

  • Enzyme Engineering for Enhanced Performance:

    • Wild-type B. bacteriovorus menD likely exhibits (R)-selectivity in carboligation reactions

    • Engineer (S)-selective variants using the S-pocket approach, targeting residues equivalent to I476 and F477 in B. subtilis menD

    • Potentially achieve higher (S)-selectivity by modifying second-shell residues that influence active site flexibility

  • Cascade Reactions: Integrate menD-catalyzed carboligation into multi-enzyme cascades for the synthesis of complex chiral compounds

Table 2: Predicted Carboligation Performance of B. bacteriovorus menD with Selected Substrates

Substrate CombinationExpected ProductPredicted StereoselectivityPotential Applications
α-ketoglutarate + benzaldehyde(R)-4-hydroxy-4-phenyl-2-oxobutanoate>90% ee (R)Pharmaceutical intermediates
α-ketoglutarate + 3-methoxybenzaldehyde(R)-4-hydroxy-4-(3-methoxyphenyl)-2-oxobutanoate>95% ee (R)Chiral building blocks
α-ketoglutarate + 3-nitrobenzaldehyde(R)-4-hydroxy-4-(3-nitrophenyl)-2-oxobutanoate>85% ee (R)Fine chemical synthesis

These predictions are based on the performance patterns observed with B. subtilis menD and would need experimental verification with the B. bacteriovorus enzyme .

What potential does B. bacteriovorus menD hold for developing novel antimicrobial approaches?

The menD enzyme from B. bacteriovorus presents several promising avenues for antimicrobial development:

The combination of menD enzymatic targets with the natural predatory capabilities of B. bacteriovorus represents a multi-dimensional approach to antimicrobial development that could address challenges posed by conventional antibiotic resistance.

How do experimental conditions affect the genetic manipulation and expression of B. bacteriovorus menD?

Successful genetic manipulation and expression of B. bacteriovorus menD require careful optimization of experimental conditions:

  • Conjugation Efficiency Factors:

    • Donor:Recipient Ratio: Optimal conjugation for B. bacteriovorus typically requires a 10:1 ratio of E. coli donor to B. bacteriovorus recipient cells.

    • Growth Phase: Predatory B. bacteriovorus should be harvested from a fresh predatory culture at attack phase.

    • Selection Pressure: Initial selection of merodiploid mutants requires kanamycin (50 μg/mL) in the upper layer of double-layer agar plates .

  • Second Crossover Induction:

    • Sucrose Concentration: 2.5% (w/v) sucrose promotes the second crossover event for marker-free genome editing.

    • Inducer Concentration: When using control elements like the Theo-F riboswitch, theophylline at 1 mM concentration effectively modulates gene expression .

  • Expression Optimization:

    • Temperature: Lower temperatures (18-25°C) often improve soluble protein yields for heterologous expression.

    • Co-factors: Supplementation with ThDP (0.1-0.5 mM) and magnesium or manganese ions (1-5 mM) enhances stability and activity of the expressed enzyme.

    • Host Selection: While E. coli is commonly used for heterologous expression, B. subtilis may offer advantages for expression of menD enzymes due to similar codon usage patterns and native ThDP-dependent enzyme processing pathways .

  • Verification Protocols:

    • PCR Confirmation: Custom primers flanking the integration site are essential for confirming successful genetic modifications.

    • Sequence Verification: Complete sequencing of the modified region is necessary to confirm the absence of unintended mutations.

    • Phenotypic Verification: Testing for kanamycin sensitivity confirms the loss of the plasmid backbone after the second crossover event .

These optimized conditions facilitate reliable genetic manipulation of B. bacteriovorus menD for both fundamental research and applied biotechnological purposes.

What data contradictions exist in the current literature regarding B. bacteriovorus menD function and how might these be resolved?

Several notable contradictions and knowledge gaps exist in the current understanding of B. bacteriovorus menD:

  • Substrate Specificity Discrepancies:

    • While menD enzymes from E. coli and B. subtilis have been characterized for their substrate preferences in both physiological and non-physiological reactions , specific data for B. bacteriovorus menD is limited.

    • The significant sequence divergence between menD orthologs (typically 20-30% identity) suggests potential differences in substrate specificity and catalytic properties that require direct experimental characterization .

  • Structural Basis for Catalysis:

    • The available structural data for E. coli menD provides a framework for understanding the enzyme mechanism , but direct structural studies of B. bacteriovorus menD are needed to resolve potential differences in active site architecture.

    • Resolving these contradictions requires X-ray crystallography or cryo-EM studies of B. bacteriovorus menD in complex with substrates and/or analogs.

  • Physiological Role in Predation:

    • The precise contribution of menaquinone biosynthesis to the predatory lifecycle of B. bacteriovorus remains incompletely characterized.

    • Targeted gene deletion or controlled expression studies using tools like the Theo-F riboswitch system could help quantify the importance of menD activity during different stages of the predatory cycle.

  • Carboligation Potential:

    • While B. subtilis menD has demonstrated excellent carboligation activity with high enantioselectivity , the performance of B. bacteriovorus menD in similar reactions is uncharacterized.

    • Side-by-side comparison studies with well-characterized orthologs would resolve uncertainties about the biocatalytic potential of B. bacteriovorus menD.

These contradictions highlight the need for comprehensive biochemical and structural characterization specific to B. bacteriovorus menD, rather than relying on extrapolations from better-studied orthologs.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.